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Signaling via G-protein coupled receptors is initiated by receptor-catalyzed nucleotide exchange on
Gα subunits normally bound to GDP and Gβγ. Activated Gα·GTP then regulates effectors such as
adenylyl cyclase. Except for Gβγ, no known regulators bind the adenylyl cyclase-stimulatory subunit
Gαs in its GDP-bound state. We recently described a peptide, KB-752, that binds and enhances the
nucleotide exchange rate of the adenylyl cyclase-inhibitory subunit Gαi. Herein, we report that
KB-752 binds Gαs·GDP yet slows its rate of nucleotide exchange. KB-752 inhibits GTPγS-stimulated
adenylyl cyclase activity in cell membranes, reflecting its opposing effects on nucleotide exchange
by Gαi and Gαs.
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1. Introduction
G-proteins serve as crucial intermediaries of extracellularly-evoked signaling cascades critical
to cellular physiology [1]. In the conventional model of heterotrimeric G-protein signaling,
extracellular cues such as hormones and neurotransmitters activate seven transmembrane
domain receptors (GPCRs) coupled to heterotrimers consisting of Gα·GDP bound to Gβγ in
the inactive state [2]. Gβγ stabilizes the GDP-bound state and prevents spontaneous nucleotide
exchange, thus serving as a guanine nucleotide dissociation inhibitor (GDI). In contrast, GPCR
activation leads to exchange of GDP for GTP on Gα, thus serving as a guanine nucleotide
exchange factor (GEF). Binding of GTP alters the conformation of three flexible “switch”
regions within Gα, causing Gβγ dissociation [3]. Both Gα·GTP and freed Gβγ can subsequently
regulate several downstream signaling components including adenylyl cylcases (ACs),
phospholipases, and ion channels responsible for the elicited cellular responses [2]. Signal
termination is achieved by the intrinsic GTP hydrolysis activity of Gα, regenerating Gα·GDP
capable of reassociation with Gβγ and thereby preventing effector interactions. Given this
bimodal nucleotide cycle, the lifetime of activated signaling is reliant on the duration of Gα in
the GTP-bound state. In this fashion, G-proteins serve as critical temporal regulators of these
pathways and thus understanding the molecular determinants underlying their nucleotide cycle
is of particular interest.
Phage display is a powerful technique for identifying small peptides capable of binding protein
targets in an unbiased manner. These peptides can then serve as tools for studying target protein
binding surfaces, protein-protein interaction sites, and protein function and regulation
[reviewed in [4]]. Phage display, along with similar approaches, has been used to investigate
G-protein binding interfaces on GPCRs and effector binding regions on Gβγ subunits, as well
as to identify peptides with regulatory properties including GEF and GDI activities [5-9]. We
recently used phage display to identify a peptide that interacts with the AC inhibitory Gα
subunit Gαi, specifically in its GDP-bound state. This peptide, KB-752, exerts GEF activity
on Gαi, the molecular determinants for which were ascertained by the Gαi1·GDP/KB-752
crystal structure [10].
Here, we demonstrate that KB-752 is capable of binding the AC stimulatory Gα subunit,
Gαs, in a GDP-selective manner similar to its interaction with Gαi. Analysis of mutations
perturbing the Gαi1/KB-752 binding interface revealed a mutation retaining activity for Gαs,
thus improving its Gα selectivity profile. Via N-terminal conjugation with the fluorescent dye
FITC, KB-752 was found to act as a sensor for the GDP-bound conformation of Gαs. However,
in contrast to its GEF activity toward Gαi, binding of KB-752 to Gαs·GDP was found to slow
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the rate of spontaneous nucleotide exchange in vitro, indicating that KB-752 is a GDI for
Gαs. Furthermore, KB-752 was capable of inhibiting both GTPγS- and forskolin-stimulated
generation of cyclic AMP by AC in cell membranes, consistent with the GDI activity of this
peptide towards Gαs, a central participant in AC regulation. Our findings suggest that the
KB-752 peptide, and variants thereof, will serve as valuable molecular tools to modulate
cellular AC activity.
2. Materials and Methods
2.1. Materials.
Unless otherwise noted, all reagents were purchased from Sigma. Peptides were synthesized
by Anaspec (San Jose, CA), except for the N-terminally FITC-labelled KB-752, the N-
terminally palmitoylated KB-752 and its scrambled and W5A mutant counterparts which were
synthesized by Dr. Michael Berne and the Tufts University Core Facility (www.tucf.org).
2.2. Protein purification.
Recombinant Gαi1 and Gαo proteins were expressed and purified as described [10]. His6-tagged
bovine Gαs (short splice variant) was purified from BL21(DE3) E. coli essentially as previously
described [11]. Briefly, protein expression from the prokaryotic plasmid pPRO-EXHTb-Gαs
was induced at an OD600 = 0.6 with 0.1 mM IPTG for 16-18 hours at 20°C. Gαs was then
purified by sequential Ni2+ nitrilotriacetate, anion exchange, and size exclusion
chromatographies [11].
2.3. Surface plasmon resonance (SPR) biosensor measurements.
All SPR binding assays were performed at 25°C on a BIAcore 3000. To analyze nucleotide-
dependent binding of KB-752 to Gαs, an N-terminally biotinylated KB-752 (diluted to 0.1
μg/ml in BIA running buffer [10 mM HEPES, pH 7.4, 150 mM NaCl, 10 mM MgCl2, and
0.005 % NP40]) was coupled to separate flow cells of streptavidin biosensor chips to a surface
density of approximately 250, 500, or 1000 response units (this variation of surface density
was used as an internal control to ensure accuracy in binding affinity calculations). Prior to
injection, Gαs was diluted in BIA running buffer containing 100 μM GDP, 100 μM GDP plus
30 μM AlCl3 and 10 mM NaF, or 100 μM GTPγS and allowed to incubate at room temperature
for 2-3 hours. Thirty microliters of Gα subunits were then simultaneously injected over flow
cells at 5 μL/min followed by a 300 sec dissociation phase. Binding to a non-Gα-interacting
peptide (C-tail of mNOTCH1, PSQITHIPEAFK; [12]) was subtracted from all binding curves
to correct for nonspecific binding and buffer shifts created during injection. Surfaces were
regenerated between each injection with two injections of 10 μL regeneration buffer (500 mM
NaCl and 25 mM NaOH) at 20 μL/min. Binding curves and kinetic analyses were conducted
using BIAevaluation software version 3.0. Binding affinities were calculated with the
simultaneous association and dissociation rate analysis parameter using generated curves.
2.4. Fluorimetric binding assays.
Assays were conducted in buffer containing 10 mM Tris/HCl, pH 8.0, 1 mM EDTA, 10 mM
MgCl2, 150 mM NaCl, and 50 μM GDP. Experiments conducted in the presence of AlF4- were
performed by supplementing the above buffer with 10 mM NaF and 30 μM AlCl3. Gαs·GDP
and Gαs·GDP·AlF4- were prepared as described for SPR. Fluorescence measurements were
made using a LS-55B spectrofluorimeter (Perkin Elmer). Timecourse measurements were
made at 5 second intervals using excitation and emission wavelengths of 494 nm and 515 nm,
respectively, and slit widths of 5 nm. Emission scans were performed at a rate of 20
nm·min-1 using an excitation wavelength of 440 nm, with slit widths of 5 nm.
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2.5. GTPγS exchange and steady-state GTPase assays.
GTPγS binding assays were conducted at 20 °C using a nitrocellulose filter binding method
detailed previously [13]. Steady-state GTPase assays were carried out at 20 °C using a charcoal
precipitation as described previously [14].
2.6. Adenylyl cyclase assays.
HEK293 cell monolayers were lysed with ice-cold hypotonic buffer (1 mM Na+-HEPES, pH
7.4, 2 mM EDTA). Scraped cell lysates were centrifuged at 30,000 × g for 20 min. The resulting
crude membrane fraction was resuspended (1 mg/ml) with a glass-teflon handheld
homogenizer (8-10 strokes) in storage buffer (15 mM Na+-HEPES, pH 7.4, 1 mM EDTA) and
frozen at -70° C until assayed. Total protein levels were determined with a BCA protein assay
kit from Pierce (Rockfield, IL). AC assays were carried out as described previously [15] with
modifications. Briefly, frozen membranes were thawed and added (15-40 μg of protein/tube)
to duplicate assay tubes containing the reaction mixture (15 mM Na+-HEPES, pH 7.4, 4.5 mM
phosphocreatine, 5 mM MgCl2, 0.25 mM ATP, 0.5 mM isobutylmethylxanthine, 3 units of
creatine phosphokinase) in a final volume of 100 μL. Incubations were carried out at 30° C,
then terminated by the addition of 200 μL 3% trichloroacetic acid. Tubes were vortexed and
centrifuged for 10 min at 14,000 x g. cAMP in the supernatant was quantified using a
competitive binding assay previously described [15] with minor modifications. Duplicate
samples of supernatants (15 μl) were added to reaction tubes. [3H]cAMP (∼1 nM final
concentration) and cAMP binding protein (ca. 150 mg) were diluted in cAMP assay buffer
(100 mM Tris/HCl pH 7.4, 100 mM NaCl, 5 mM EDTA) and then added to each well for a
total volume of 550 μL. The tubes were incubated on ice for 2 hr and harvested by filtration
(Packard Unifilter GF/C) using a 96-well Packard Filtermate Cell harvester (Meriden, CT).
The filters were allowed to dry, and Microscint O scintillation fluid was added. Filter
radioactivity was determined using a Packard TopCount scintillation/luminescence detector.
cAMP concentrations in each sample were estimated in duplicate from a standard curve ranging
from 0.1 to 300 pmol of cAMP per assay.
3. Results and Discussion
3.1 Nucleotide selective interaction between KB-752 and Gαs:
We previously demonstrated that the phage display-derived peptide KB-752
(SRVTWYDFLMEDTKSR) interacts preferentially with the GDP-bound conformation of
Gαi1 (KD of ∼4 μM; [10]). We have since found that KB-752 also interacts with Gαs in a GDP-
selective manner (Figure 1). In SPR binding assays, immobilized KB-752 peptide showed a
robust interaction with recombinant Gαs in the presence of GDP; no detectable interaction was
seen with Gαs in either the GDP·AlF4-- or GTPγS-bound states (Figure 1A). Using
simultaneous kon and koff rate calculations, the apparent dissociation constant (KD) for the
KB-752/Gαs·GDP interaction was found to be 5.1 ± 0.9 μM (Figure 1B). These results indicate
that KB-752 interacts selectively with the inactive, GDP-bound state of Gαs with an affinity
similar to that for its original target interactor, Gαi1·GDP.
The nucleotide state-selective nature of the Gα/KB-752 interaction suggests a possible
application of peptides such as KB-752 as specific sensors for Gα conformational state. As
proof-of-principle for such an application, we tested a KB-752 variant containing a covalently-
linked N-terminal fluorescein isothiocyanate (FITC) group. Adding Gαs·GDP to a solution
containing FITC-KB-752 resulted in an increase in fluorescence intensity above baseline
(Figure 1C). Importantly, addition of Gαs·GDP·AlF4- showed no change in fluorescence
response. These results suggest that fluorescent dye-labelled KB-752 can serve as a biosensor
for the GDP-bound conformation of Gαs. Analysis of the emission spectrum of FITC-KB-752
prior to and following the addition of Gαs·GDP indicates an ∼20% increase in overall
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fluorescence intensity yield (Figure 1C inset). Thus, while this modified peptide represents a
potentially novel tool for studying Gαs activation/deactivation dynamics in vitro [16], further
development strategies to increase the change in fluorescence quantum yield will be required
for its utility in in vivo applications.
3.2 GDI activity of KB-752 toward Gαs:
KB-752 serves as a guanine nucleotide exchange factor for Gαi1, Gαi2, and Gαi3 subunits
[10]. In contrast, KB-752 slowed the rate of spontaneous nucleotide exchange by Gαs, as
measured by the binding of [35S]GTPγS (Figure 2A). The effective concentration for 50% of
maximal GDI activity (EC50) toward Gαs was 4.5 ± 1.9 μM (Figure 2B), agreeing closely with
the observed binding affinity. To confirm this GDI activity, we also measured the effect of
KB-752 on the steady-state GTPase rate of Gαs. Given that GDP release is the rate-limiting
step in the guanine nucleotide cycle for isolated Gα subunits [17], any modulation of nucleotide
exchange is reflected in the overall steady-state rate [14]. KB-752 association was found to
reduce the steady-state GTPase rate of Gαs (Figure 2C), further supporting the discovery of
GDI activity for this peptide/Gα pairing.
Gβγ serves as the prototypical GDI in the conventional model of GPCR-mediated signal
transduction. Gβγ binds Gα·GDP and couples the resulting heterotrimer to receptor, as well as
preventing spontaneous GDP release [18,19]. More recently, we and others have described the
GoLoco motif within several proteins that binds Gαi family members and slows spontaneous
release of GDP [11,20-22]. However, the GoLoco motif does not interact with nor serve as a
GDI for Gαs [20], and no similar protein domain has been identified for Gαs to date. Thus,
KB-752 serves as a unique peptide capable of serving as a GDI for Gαs.
3.3 Inhibition of AC activity by KB-752:
Gαs·GTP stimulates the ability of AC to generate cAMP from ATP, whereas Gαi family
members inhibit AC activity when in their GTP-bound state. Thus, we hypothesized that
KB-752, by virtue of its GDI activity on Gαs and GEF activity on Gαi [10], could inhibit AC
activity by modulating the balance of stimulatory and inhibitory inputs from Gα subunits. To
test this idea, we incubated HEK293 cell membranes with an N-terminally palmitoylated
version of KB-752 and examined cAMP accumulation. Palmitoylated KB-752 peptide was
found to inhibit GTPγS-stimulated cAMP accumulation, whereas a sequence-scrambled,
control palmitoylated peptide did not significantly affect cAMP accumulation (Figure 3).
KB-752 had no effect on basal cAMP accumulation. These results suggest that KB-752 can
modulate G-protein activation in a cellular context and in a manner consistent with its effects
measured using purified Gα subunits.
3.4 Generation of a KB-752 variant with improved Gα selectivity:
Our study of the structural determinants of KB-752 binding to Gαi1·GDP indicated that residues
W5, F8, and E11 within KB-752 make critical contacts with Gαi1; for example, mutating either
the W5 or F8 positions to alanine results in a loss of Gαi1 binding and GEF activity on Gαi1
[10]. We investigated the effects of these two mutations on the KB-752/Gαs interaction.
Whereas the W5A mutant peptide retained Gαs association and GDI activity (albeit with an
accelerated off-rate; Figure 4A), the F8A mutation abrogated both binding and GDI activity
toward Gαs (Figure 4A,B). These results suggest that F8, but not W5, is critical to the interaction
of KB-752 with Gαs. Our findings identify KB-752(W5A) as a Gαs-selective variant of KB-752
that retains the ability to inhibit GTPγS-stimulated AC activation (Figure 4C), although more
weakly than that of wildtype, presumably reflecting its loss of Gαi-directed GEF activity and/
or reduction in Gαs affinity. Both wildtype and W5A mutant palmitoylated KB-752 peptides
were also capable of inhibiting forskolin-stimulated AC activity (Figure 4C); this inhibition is
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likely related to Gαs-directed GDI activity, as Gαs and forskolin are known to activate various
AC isoforms in a synergistic fashion [23,24].
Although attempts to crystallize a Gαs·GDP/KB-752 complex have not yet succeeded, several
predictions can be made as to the structural determinants of this interaction. First, in light of
its nucleotide-dependent nature, the Gαs·GDP/KB-752 interaction presumably involves one or
more of the three switch regions of Gαs that undergo conformational changes throughout the
nucleotide cycle [25]. Second, while the structural determinants for KB-752 binding to Gαs
may partially overlap with those for Gαi1 binding (e.g., F8 in KB-752 is critical for binding
both targets), the exact interactions and relative positions of the KB-752 binding interface likely
differs. This is underscored by the W5A mutant which retains activity towards Gαs. This
tryptophan residue participates in critical Gαi1 contacts and underlies the GDP-dependent
binding [10]. The hydrophobic binding pocket in Gαi1 responsible for KB-752 binding (i.e.,
the cleft between the α2 and α3 helices) represents a highly conserved region within Gα
subunits, including Gαs. Thus, while the F8 residue of KB-752 is still critical for interaction
with Gαs (Figure 4), the dispensability of W5 suggests a different interaction site with Gαs
versus Gαi1, perhaps a shift in peptide orientation within the α2/α3 hydrophobic groove. Third,
KB-752 may make direct contact with the bound GDP within Gαs and/or bind in a manner that
occludes its release. This mode of binding is seen in GoLoco-induced inhibition of GDP release
from Gαi1 [21]. Alternatively, KB-752-mediated GDI activity could arise by the repositioning
of the switch regions such as to inhibit GDP release.
In conclusion, we have found that KB-752 binds to the AC-stimulatory Gαs protein in a GDP-
selective manner. We had previously shown that KB-752 interacts with Gαi1 in a similar
nucleotide-dependent manner [10]. Whereas KB-752 has GEF activity for Gαi1, we
demonstrate here that KB-752 possesses the diametrically-opposite biochemical activity for
Gαs, namely GDI activity. These opposing activities on Gαi and Gαs result in an inhibition of
cAMP production via G protein-modulated AC activity in cell membrane preparations. We
serendipitously found a mutation (W5A) that prevents binding of KB-752 to Gαi1, thereby
creating a more selective peptide that could be used to perturb Gαs signaling without affecting
Gαi-mediated processes. Our observation that the Gαs-selective KB-752(W5A) variant retains
the ability to decrease GTPγS- and forskolin-stimulated AC activity suggests that the
predominant mechanism of action of KB-752 as an AC inhibitor resides in its GDI activity
towards Gαs. Although the sequence of KB-752 does not correspond to any naturally-occurring
sequence [10], its nucleotide-dependent binding and GDI activity make it a potentially
powerful molecular tool for studying Gαs signaling.
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Nucleotide-dependent binding of KB-752 to Gαs. (A) 10 μM of Gαs (“Analyte”), in each of
the indicated nucleotide bound states, was injected over immobilized KB-752 and binding
measured by SPR. Non-specific binding to a control biotinylated peptide surface was
subtracted from each curve. (B) Gαs, Gαo, and Gαi1 were separately injected at increasing
concentrations (0.01 to 50 μM) over immobilized KB-752 to determine the dissociation
constants (KD) for each interaction pair as obtained from simultaneous kon/koff analyses (n =
4-6 for each state). (C) Time course of FITC-KB-752 binding to Gαs. 100 nM FITC-KB-752
was equilibrated in buffer containing either GDP (black trace) or GDP·AlF4- (grey trace) and
background fluorescence subtracted. At 50 seconds, 1 μM Gαs·GDP (black trace) or 1 μM
Gα·GDP·AlF4- (grey trace) was added. (Inset) Emission scans of FITC-KB-752 in the absence
and presence of Gαs·GDP obtained using an excitation wavelength of 440 nm.
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. GDI activity of KB-752 on Gαs assessed by GTPγS binding and steady-state GTPase
measurements. (A) 50 nM Gαs was incubated in the absence or presence of 5 μM KB-752 for
15 minutes at room temperature prior to addition of [35S]GTPγS. Duplicate reaction aliquots
were removed at indicated times and protein-bound radioactivity counted. (B) 50 nM Gαs or
Gαo was incubated with the indicated concentrations of KB-752 as in (A) and GTPγS binding
reactions were incubated at 20 °C for 5 minutes. (C) 100 nM Gαo or Gαs was incubated with
10 μM KB-752 for 15 minutes at room temperature prior to the addition of [γ-32P]GTP and
measurement of released [32P] inorganic phosphate.
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. Effect of KB-752 on adenylyl cyclase activity. Basal or 10 μM GTPγS-stimulated cAMP
accumulation over 10 minutes was measured from HEK293 cell membrane preparations in the
absence (vehicle) or presence of 30 μM wildtype, palmitoylated KB-752 or a sequence-
scrambled version. *, p < 0.05 compared to vehicle; one-way ANOVA followed by Dunnett's
(n = 4). Inset: HEK293 membrane preparations were stimulated with 10 μM GTPγS in the
presence of indicated molar concentrations of wildtype palmitoylated KB-752 and cAMP
accumulation was measured following 10 minutes. Data are shown as the mean ± SEM of 4
independent experiments and expressed as percent of cAMP generated in the absence of
peptide.
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. Effects of alanine substitutions to KB-752 binding, GDI activity, and attenuation of AC
activation. (A) N-terminally biotinylated KB-752 mutant (W5A, F8A) or wildtype peptides
were each immobilized to a density of ∼1000 response units (RUs) on separate streptavidin-
coated flow cells and 25 μM of GDP-bound Gαs (“Analyte”) was injected simultaneously over
all surfaces. (B) Purified Gαs or Gαi1 was incubated with the indicated KB-752 peptide and
[35S]GTPγS binding was measured following incubation for 5 minutes at 20 °C. (C) cAMP
accumulation over 10 minutes at 30 °C was measured from HEK293 cell membrane
preparations stimulated with 10 μM GTPγS or 30 μM forskolin (FSK) in the absence (vehicle)
Johnston et al. Page 11













or presence of 30 μM wildtype, palmitoylated KB-752 (wt) or the tryptophan-5 substituted
version (W5A). *, p < 0.05; **, p < 0.01 compared to vehicle; one-way ANOVA followed by
Dunnett's (n = 3).
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